Sofinnova Investments, Inc. Geron Corp Transaction History

Sofinnova Investments, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 15, 2024	BUY	$1.74 - $2.31 $15.3 Million - $20.4 Million	8,814,497 New	8,814,497 $18.6 Million
Q4 2023 Feb 12, 2024	BUY	$1.74 - $2.31 $5.89 Million - $7.82 Million	3,385,342 Added 62.35%	8,814,497 $18.6 Million
Q2 2023 Aug 14, 2023	SELL	$1.97 - $3.69 $5.61 Million - $10.5 Million	-2,845,737 Reduced 34.39%	5,429,155 $17.4 Million
Q1 2023 May 11, 2023	BUY	$2.14 - $3.4 $14.6 Million - $23.2 Million	6,815,303 Added 466.93%	8,274,892 $18 Million
Q4 2022 Feb 13, 2023	BUY	$2.03 - $2.42 $548,873 - $654,322	270,381 Added 22.74%	1,459,589 $3.53 Million
Q3 2022 Nov 08, 2022	SELL	$1.67 - $2.94 $2.68 Million - $4.71 Million	-1,602,422 Reduced 57.4%	1,189,208 $2.78 Million
Q2 2022 Aug 15, 2022	BUY	$1.19 - $1.65 $1.06 Million - $1.46 Million	886,868 Added 46.56%	2,791,630 $4.33 Million
Q1 2022 May 16, 2022	BUY	$0.99 - $1.6 $1.89 Million - $3.05 Million	1,904,762 New	1,904,762 $2.59 Million

276

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.08B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.